# Prospective Clinical Assessment Study in Children With Hypochondroplasia

> **NCT06410976** · — · RECRUITING · sponsor: **QED Therapeutics, a BridgeBio company** · enrollment: 150 (estimated)

## Conditions studied

- Hypochondroplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06410976
- **Lead sponsor:** QED Therapeutics, a BridgeBio company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-05
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06410976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06410976, "Prospective Clinical Assessment Study in Children With Hypochondroplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06410976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*